$12.49
-0.0098-0.08%
Pre-Market: 4:37 PM EDT
15 minutes delayed
Comments
Loading...
Zymeworks (NASDAQ:ZYME) Stock Quotes, Forecast and News Summary
Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zymeworks (ZYME) stock?
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Who are Zymeworks (ZYME) competitors?
Other companies in Zymeworks’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL), Prothena Corp (NASDAQ:PRTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the forecast, or price target, for Zymeworks (ZYME) stock?
Zymeworks has a consensus price target of $19.71.
What is the current price for Zymeworks (ZYME)?
The stock price for Zymeworks (NASDAQ: ZYME) is $12.4902 last updated September 24, 2024 at 4:37 PM EDT.
Does Zymeworks (ZYME) pay a dividend?
There are no upcoming dividends for Zymeworks.
When is Zymeworks (NASDAQ:ZYME) reporting earnings?
Zymeworks’s Q3 earnings are confirmed for Friday, November 1, 2024.
Is Zymeworks (ZYME) going to split?
There is no upcoming split for Zymeworks.
What sector and industry does Zymeworks (ZYME) operate in?
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.